Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More

Apexbio Technology LLC Cefotaxime (sodium salt)(Synonyms: Claforan, Cefotaxime Sodium, Cefotaxim sodium salt, Cefotaxime Na, Sodium cefotaxime), 1g, CAS: 64485-93-4.
SDP

Supplier:  Apexbio Technology LLC C45881000

Encompass_Preferred

Cefotaxime sodium (CAS 64485-93-4) is a third-generation cephalosporin antibiotic belonging to the -lactam group characterized by inhibition of bacterial cell-wall synthesis through binding to penicillin-binding proteins In vitro analyses show strong inhibitory efficacy against various bacterial species notably cefotaxime exhibits an MIC below 0 1 g/ml against Streptococcus pneumoniae It also demonstrates high activity against Haemophilus influenzae including -lactamase-producing strains In vivo mouse model studies revealed that combination therapy of cefotaxime with minocycline enhanced survival following Vibrio vulnificus infection compared to single-agent treatments Clinically cefotaxime has been evaluated in pneumonia therapy demonstrating good tolerance and therapeutic utility in targeting susceptible bacterial pathogens

Catalog No. 50-000-61234


May include imposed supplier surcharges.
Only null left
Add to Cart

Product Content Correction

The Fisher Scientific Encompass Program offers items which are not part of our distribution portfolio. These products typically do not have pictures or detailed descriptions. However, we are committed to improving your shopping experience. Please use the form below to provide feedback related to the content on this product.

Product Title

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.

Your feedback has been submitted: Thank you for helping us improve our website.